Leap Therapeutics (LPTX) Rebrands as “Cypherpunk,” Buys $50M in Zcash; Ticker to Change to CYPH on Nov. 13 — Q3 Results and New $200M ATM Filed (Nov. 12, 2025)
Leap Therapeutics, Inc. (Nasdaq: LPTX) unveiled a sweeping strategic pivot today: the oncology company is rebranding as Cypherpunk Technologies Inc., has already purchased ~$50 million of Zcash (ZEC) for a new digital‑asset treasury strategy, and will switch its Nasdaq ticker from LPTX to CYPH at the open on Thursday, Nov. 13, 2025. The company also filed fresh SEC documents, including Q3 2025 results and a $200 million at‑the‑market (ATM) equity program with Cantor Fitzgerald. PR Newswire+2SEC+2 What changed — and why it matters Rebrand & crypto‑treasury pivot. In a 7:00 a.m. ET release, the company said it will adopt the